[Cyclophosphamide in ANCA associated vasculitis: continuous oral vs pulse therapy].
U.O. di Nefrologia, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italy. nicoletta.serpier@gmail.com
Nicoletta
N
Serpieri
D000284:Administration, Oral; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000188:drug therapy* / Q000276:immunology; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D020551:Pulse Therapy, Drug; D016896:Treatment Outcome
D019268:Antibodies, Antineutrophil Cytoplasmic; D015415:Biomarkers; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide